13F Pro

SEC Form 4 reporting owner

Venker Eric

Venker Eric has filed 29 Form 4 transactions reported between December 9, 2025 and August 28, 2026, as President & Immunovant CEO of Roivant Sciences Ltd. and Chief Executive Officer of Immunovant, Inc..

Name as filed: Venker Eric

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$20.4M
9 lines
Companies
2
with Form 4 filings
Latest transaction
Aug 28, 2026
transaction date

Roles and reported holdings

  • ROIVRoivant Sciences Ltd.
    Dec 9, 2025 – Aug 28, 2026

    President & Immunovant CEO

    Held directly1,599,154 sh as of Aug 28, 2026 · Form 4

    24 months: $20.0M sold

  • IMVTImmunovant, Inc.
    Apr 1, 2026 – Jul 2, 2026

    Chief Executive Officer

    Held directly254,280 sh as of Jul 2, 2026 · Form 4

    24 months: $462K sold

Transaction history

All 29 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 28, 2026ROIVPresident & Immunovant CEOOpen-market saleCode S · direct33,818$1.2M@ $36.44Form 4
Aug 28, 2026ROIVPresident & Immunovant CEOOpen-market saleCode S · direct166,182$5.9M@ $35.63Form 4
Aug 28, 2026ROIVPresident & Immunovant CEOOption exerciseCode M · direct200,000$770K@ $3.85Form 4
Aug 20, 2026ROIVPresident & Immunovant CEOShares withheld for tax or exercise priceCode F · direct13,909$512K@ $36.84Form 4
Jul 27, 2026ROIVPresident & Immunovant CEOOption exerciseCode M · direct200,000$770K@ $3.85Form 4
Jul 2, 2026IMVTChief Executive OfficerOpen-market saleCode S · direct3,092$119K@ $38.48Form 4
Jul 1, 2026IMVTChief Executive OfficerDisposition to issuerCode D · direct86,629$3.3M@ $38.14Form 4
Jul 1, 2026IMVTChief Executive OfficerOption exerciseCode M · direct92,188$1.3M@ $14.46Form 4
Jun 24, 2026ROIVPresident & Immunovant CEOOpen-market saleCode S · direct46,234$1.5M@ $33.51Form 4
Jun 24, 2026ROIVPresident & Immunovant CEOOpen-market saleCode S · direct153,766$5.1M@ $33.05Form 4
Jun 24, 2026ROIVPresident & Immunovant CEOOption exerciseCode M · direct200,000$770K@ $3.85Form 4
May 22, 2026ROIVPresident & Immunovant CEOOption exerciseCode M · direct200,000$770K@ $3.85Form 4
May 20, 2026ROIVPresident & Immunovant CEOShares withheld for tax or exercise priceCode F · direct34,483$1.1M@ $32.41Form 4
Apr 20, 2026ROIVPresident & Immunovant CEOOption exerciseCode M · direct200,000$770K@ $3.85Form 4
Apr 7, 2026IMVTChief Executive OfficerGrant or awardCode A · direct336,043—Form 4
Apr 7, 2026IMVTChief Executive OfficerGrant or awardCode A · direct232,252—Form 4
Apr 2, 2026IMVTChief Executive OfficerOpen-market saleCode S · direct1,409$35K@ $24.60Form 4
Apr 2, 2026IMVTChief Executive OfficerOpen-market saleCode S · direct12,820$308K@ $24.04Form 4
Apr 1, 2026IMVTChief Executive OfficerDisposition to issuerCode D · direct334,960$8.4M@ $25.10Form 4
Apr 1, 2026IMVTChief Executive OfficerOption exerciseCode M · direct368,750$5.3M@ $14.46Form 4
Mar 17, 2026ROIVPresident & Immunovant CEOOption exerciseCode M · direct200,000$770K@ $3.85Form 4
Feb 20, 2026ROIVPresident & Immunovant CEOShares withheld for tax or exercise priceCode F · direct7,051$191K@ $27.15Form 4
Feb 13, 2026ROIVPresident & Immunovant CEOOption exerciseCode M · direct200,000$770K@ $3.85Form 4
Jan 12, 2026ROIVPresident & Immunovant CEOOption exerciseCode M · direct200,000$770K@ $3.85Form 4
Dec 24, 2025ROIVPresident & Immunovant CEOOpen-market saleCode S · direct75,000$1.7M@ $22.53Form 4
Dec 24, 2025ROIVPresident & Immunovant CEOOption exerciseCode M · direct117,848$454K@ $3.85Form 4
Dec 23, 2025ROIVPresident & Immunovant CEOOpen-market saleCode S · direct200,000$4.5M@ $22.45Form 4
Dec 23, 2025ROIVPresident & Immunovant CEOOption exerciseCode M · direct313,841$1.2M@ $3.85Form 4
Dec 9, 2025ROIVPresident & Immunovant CEOOption exerciseCode M · direct200,000$770K@ $3.85Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.